Epidemic

Moderna Reviews its Environmental, Social and Governance (ESG) Progress and Ambitions at Second ESG Investor Event

Retrieved on: 
Monday, December 11, 2023
Biophysical environment, Patient, Epidemic, Science, Partnership, Culture, Virus, Messenger, Vaccine, Access, Health, ESG, CEPI, Disclosure, Coalition, Social, MRNA, Public, Global health, Organization, Corporation, Environment

We look forward to building on our substantial ESG progress to become the best version of Moderna."

Key Points: 
  • We look forward to building on our substantial ESG progress to become the best version of Moderna."
  • Within its clinical trials, Moderna believes a committed approach to offering equal healthcare accessibility is achievable and necessary.
  • Governance & Ethics: Moderna prioritizes accountability and transparency around its ESG efforts, including through the publication of its second annual ESG report and continued commitment to disclosing key metrics.
  • To register for the live webcast of Moderna's ESG Investor Event, visit https://moderna-esg-day-2023.open-exchange.net/registration.

NextEra Energy Partners, LP completes sale of Texas natural gas pipeline portfolio

Retrieved on: 
Thursday, December 28, 2023
NextEra Energy Resources, Risk, Government, Health, KMI, Hart–Scott–Rodino Antitrust Improvements Act, News, Personal injury, Nature, Annual report, Multimedia, Projection, NEP, Foreign Sovereign Immunities Act, NextEra Energy Partners, Epidemic, Pandemic, STX, Professional, Insurance, NEE, Weather, Affect, G&A, Natural gas, NextEra Energy, Environment, Failure, Form 10-K, Partnership, PPA, Partner, Sale, Wind, Acquisition, Public expenditure, IDR, Pressure, Financial services

JUNO BEACH, Fla., Dec. 28, 2023 /PRNewswire/ -- NextEra Energy Partners, LP (NYSE: NEP) today announced it has closed on its previously disclosed agreement with Kinder Morgan, Inc. (NYSE: KMI) to sell its Texas natural gas pipeline portfolio for $1.815 billion.

Key Points: 
  • JUNO BEACH, Fla., Dec. 28, 2023 /PRNewswire/ -- NextEra Energy Partners, LP (NYSE: NEP) today announced it has closed on its previously disclosed agreement with Kinder Morgan, Inc. (NYSE: KMI) to sell its Texas natural gas pipeline portfolio for $1.815 billion.
  • "With the Texas natural gas pipeline portfolio sale complete, the partnership has sufficient proceeds available to address the equity buyouts of the STX Midstream and NEP Renewables II convertible equity portfolio financings."
  • The Texas natural gas pipeline portfolio is primarily comprised of seven pipelines, which provide natural gas to Mexico and power producers and municipalities in South Texas.
  • The total 2023 calendar-year adjusted EBITDA for the Texas natural gas pipeline portfolio is expected to be approximately $180 million, with roughly 70% associated with the transmission portion of the portfolio and the remaining 30% associated with the midstream pipelines.

New partnership aims to advance vaccine against MERS coronavirus

Retrieved on: 
Thursday, December 21, 2023
Epidemic, Partnership, Immune system, University of Oxford, Infection, PRIME, EMA, Urinary tract infection, Barinthus, WHO, Oxford–AstraZeneca COVID-19 vaccine, Vaccine, MERS, MERS-related coronavirus, CEPI, Vaccination, Coalition, Clinical trial, Cancer, University, ChAdOx1, COVID-19, European Medicines Agency, Policy, Public, Coronavirus, Phase II, Medicine, Public health, Autoimmunity, Pharmaceutical industry

“We had a head-start in our development of the Oxford/AstraZeneca COVID-19 vaccine, thanks to the many years already spent researching a vaccine for another coronavirus, MERS.

Key Points: 
  • “We had a head-start in our development of the Oxford/AstraZeneca COVID-19 vaccine, thanks to the many years already spent researching a vaccine for another coronavirus, MERS.
  • “There is an active need for a MERS vaccine for at-risk populations and travellers in the Middle East.
  • MERS is a severe respiratory infection caused by MERS-CoV, a coronavirus that was first identified in 2012 in Saudi Arabia.
  • The vaccine will be made available to low- and middle-income countries at a price no higher than the cost of manufacturing plus 10 percent.

BioNTech Achieves Milestone at mRNA-based Vaccine Manufacturing Site in Rwanda

Retrieved on: 
Monday, December 18, 2023
RNA, Entrepreneurship, Epidemic, Partnership, Pasteur Institute, Government, State, African, Messenger, Research, WHO, Excellency, Vaccine, Mortality, Quality control, BNTX, CEPI, Republic, Coalition, Laboratory, BioNTech, COVID-19, HIV, Tuberculosis, World Health Organization, Mpox, Infection, Child

President Paul Kagame of Rwanda, Heads of State and Government from Africa and around the world, leadership of the African Union and European Union, as well as from WHO, Africa CDC and CEPI attended the official inauguration of the BioNTech site in Kigali

Key Points: 
  • President Paul Kagame of Rwanda, Heads of State and Government from Africa and around the world, leadership of the African Union and European Union, as well as from WHO, Africa CDC and CEPI attended the official inauguration of the BioNTech site in Kigali
    KIGALI, Rwanda, December 18, 2023 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) has reached the next milestone in the establishment of mRNA vaccine manufacturing capacities in Africa with the inauguration of the Company’s site in Kigali, Rwanda.
  • The Company’s manufacturing site in Kigali could become the first commercial-scale mRNA manufacturing facility on the continent.
  • In 2024, BioNTech expects to complete all buildings on site, including a warehouse, offices and laboratories for quality control.
  • BioNTech plans to conduct clinical trials in Africa for vaccine candidates against malaria, tuberculosis and HIV in 2024.

GOGL – Third Quarter 2023 Results

Retrieved on: 
Tuesday, November 21, 2023
Piracy, Euro, Policy, Tax, Epidemic, Pandemic, PSLRA, Sale, Government, Acquisition, Loss, Public expenditure, Disclosure, Accident, Social, Insurance, Public, Investment, Transport, Safety, Security (finance), Annual report

The Company is taking advantage of the safe harbor provisions of the PSLRA and is including this cautionary statement in connection therewith.

Key Points: 
  • The Company is taking advantage of the safe harbor provisions of the PSLRA and is including this cautionary statement in connection therewith.
  • The Company cautions that assumptions, expectations, projections, intentions and beliefs about future events may and often do vary from actual results and the differences can be material.
  • These forward-looking statements are not guarantees of the Company’s future performance, and actual results and future developments may vary materially from those projected in the forward-looking statements.
  • This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.

mRNA Therapeutics and Global Markets - MRNA Therapeutics Market Sees Robust Growth as Global Demand for Revolutionary Medical Treatments Surges - ResearchAndMarkets.com

Retrieved on: 
Thursday, December 28, 2023
Biotechnology, Pharmaceutical, Genetics, Health, Epidemic, Pandemic, Messenger, Research, Viral protein, FDA, Vaccine, MERS, Therapy, CRISP, Confusion, COVID-19, SARS, Developed country, Infection

The global market for mRNA therapeutics reached $60 billion in 2022 and is estimated to reach $21 billion by the end of 2028.

Key Points: 
  • The global market for mRNA therapeutics reached $60 billion in 2022 and is estimated to reach $21 billion by the end of 2028.
  • The COVID-19 pandemic created a niche market for mRNA therapeutics, particularly vaccines.
  • The fast-paced development of mRNA vaccines was possible due to advancement in sequencing as well as two decades of previous research on mRNA drugs.
  • This report focuses on the mRNA therapeutics market and includes the types of mRNA and their application in therapy.

New Fortress Energy Adds 1.6 GW, 15-year Contracted Power Asset to Existing Brazilian Infrastructure Portfolio

Retrieved on: 
Wednesday, December 27, 2023
Energy, Utilities, Oil, Gas, BTG Pactual, Failure, Epidemic, PPA, Trust, Pandemic, Mineral, Acquisition, Mining, TGS, Energy transition, Health, Risk, COD, Metal, COVID-19, Coronavirus, Growth, Safety, Security (finance), Ship, Wes Edens, Natural gas, Communication, Renewable energy

NFE plans to leverage its existing infrastructure in Brazil and transfer the PPA to new power assets connected to NFE’s existing Brazilian LNG terminals – Barcarena and Terminal Gas Sul (“TGS”).

Key Points: 
  • NFE plans to leverage its existing infrastructure in Brazil and transfer the PPA to new power assets connected to NFE’s existing Brazilian LNG terminals – Barcarena and Terminal Gas Sul (“TGS”).
  • By using its existing asset base, NFE expects to reduce costs and generate incremental throughput and earnings at its terminals.
  • With the acquisition of the PPA, NFE adds significant downstream power infrastructure to its asset base, enabling further utilization of its existing terminal infrastructure in Barcarena and TGS.
  • About New Fortress Energy Inc.
    New Fortress Energy Inc. (NASDAQ: NFE) is a global energy infrastructure company founded to address energy poverty and accelerate the world’s transition to reliable, affordable, and clean energy.

AngloGold Ashanti to Make a Strategic Investment in G2 Goldfields Inc.

Retrieved on: 
Tuesday, December 19, 2023
Mining, Minerals, Natural Resources, Documentation, Epidemic, Annual report, Mineral Resources Limited, Resource, Pandemic, Government, Guiana Shield, Form, Gold, Health, Public expenditure, AngloGold Ashanti, Accident, Risk, Communication, COVID-19, Radius, OKO, Subscription business model, F-4, Rare-earth element

G2 is actively exploring in Guyana, a country which hosts the Guiana Shield, one of the world’s most prospective gold provinces.

Key Points: 
  • G2 is actively exploring in Guyana, a country which hosts the Guiana Shield, one of the world’s most prospective gold provinces.
  • Commenting on the Subscription, Alberto Calderon, CEO of AngloGold Ashanti said, “This strategic investment in G2 will provide us with a strong position in one of the world’s key gold provinces with significant potential for new discoveries.
  • In this communication, AngloGold Ashanti relies on information publicly disclosed by G2 pertaining to the OKO Main Zone deposit and by Reunion Gold pertaining to the OKO West discovery.
  • AngloGold Ashanti has not independently verified this information and is not treating such information as a current estimate of Mineral Resources, Mineral Reserves or exploration results.

OVIAR and SOiVA Announce New Venture, B5G6G Telecom, to Advance South Korean Resilience

Retrieved on: 
Tuesday, December 19, 2023
Samsung, Telecom, Epidemic, Government, IOT, Telecommunications, City, KT Corporation, DCI, Data, AI, Internet, TTA, Mobile phone

WASHINGTON, Dec. 19, 2023 /PRNewswire-PRWeb/ -- Today, OVIAR Global Resilience Systems (OVIAR) and SOiVA, a data and telecommunications company based in South Korea, announced their intent to launch a joint venture called B5G6G Telecom (short for "Beyond 5G6G Telecom"). B5G6G Telecom will launch in Gangwon Province, South Korea in January 2024 to lead development of a local resilience system. The system will be the first of over 250 regional resilience systems to be built across South Korea, forming one of the world's most advanced communications and computing technology platforms.

Key Points: 
  • Beginning in January 2024, B5G6G Telecom will lead development in Gangwon Province, South Korea of a local resilience system.
  • WASHINGTON, Dec. 19, 2023 /PRNewswire-PRWeb/ -- Today, OVIAR Global Resilience Systems (OVIAR) and SOiVA, a data and telecommunications company based in South Korea, announced their intent to launch a joint venture called B5G6G Telecom (short for "Beyond 5G6G Telecom").
  • B5G6G Telecom will launch in Gangwon Province, South Korea in January 2024 to lead development of a local resilience system.
  • "B5G6G Telecom will unite SOiVA's advanced technology with OVIAR's global experience in building resilience systems and networks," said OVIAR CEO Michael McDonald.

New Series with Harvesting Happiness and Mental Immunity Project Explores Information Warfare, AI, Reality Testing and the Decline of Critical Thinking in Society

Retrieved on: 
Tuesday, December 19, 2023
Quality of life, Science, MIP, Epidemic, Culture, Immunology, Health, AI, LOS, KBUU-LP, Mind, Radio, HH, Carnegie Mellon University

LOS ANGELES, Dec. 19, 2023 /PRNewswire/ -- Andy Norman, Pittsburg researcher and professor at Carnegie Mellon University, author of Mental Immunity, and founder of the Mental Immunity Project (MIP) and its research arm The Cognitive Immunology Research Collaborative (CIRCE), joins Lisa Cypers Kamen, applied positive psychology expert, online talk-radio pioneer and host of syndicated podcast and terrestrial radio show Harvesting Happiness (HH), now in its 13th year of broadcasting consciously prepared brain food. Together, they embark on an 18-part series exploring the emerging science of cognitive immunology to defend against fear mongering and other negative contagions that stem from misinformation, disinformation, and infectious mindbugs undermining common sense and critical thinking that affect personal and collective well-being.

Key Points: 
  • "The series aims to empower truth-seekers and truth-tellers through rational dialogue, tackling media literacy and AI's impact on diminishing critical thinking and discernment in society.
  • The Mental Immunity Project and Harvesting Happiness enhance quality of life and productivity by building mental resilience, media intelligence, and critical thinking against misinformation.
  • Learn more about CIRCE , the Mental Immunity Project and Harvesting Happiness .
  • Please contact [email protected] for more information on the series or to book interviews with the collaborators.